nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0373	0.0462	CbGbCtD
Erythromycin—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0346	0.0427	CbGbCtD
Erythromycin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0322	0.0398	CbGbCtD
Erythromycin—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0288	0.0356	CbGbCtD
Erythromycin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0283	0.035	CbGbCtD
Erythromycin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0283	0.035	CbGbCtD
Erythromycin—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0279	0.0345	CbGbCtD
Erythromycin—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0253	0.0312	CbGbCtD
Erythromycin—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0253	0.0312	CbGbCtD
Erythromycin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.021	0.0259	CbGbCtD
Erythromycin—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0207	0.0256	CbGbCtD
Erythromycin—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0194	0.024	CbGbCtD
Erythromycin—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0194	0.024	CbGbCtD
Erythromycin—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0185	0.0228	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0185	0.0228	CbGbCtD
Erythromycin—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0176	0.0217	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0159	0.0197	CbGbCtD
Erythromycin—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0159	0.0197	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0155	0.0191	CbGbCtD
Erythromycin—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0155	0.0191	CbGbCtD
Erythromycin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0153	0.0189	CbGbCtD
Erythromycin—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0182	CbGbCtD
Erythromycin—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.014	0.0173	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0173	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.014	0.0173	CbGbCtD
Erythromycin—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0173	CbGbCtD
Erythromycin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0138	0.0171	CbGbCtD
Erythromycin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0138	0.0171	CbGbCtD
Erythromycin—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0165	CbGbCtD
Erythromycin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0121	0.015	CbGbCtD
Erythromycin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.012	0.0148	CbGbCtD
Erythromycin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0116	0.0143	CbGbCtD
Erythromycin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0114	0.0141	CbGbCtD
Erythromycin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0114	0.0141	CbGbCtD
Erythromycin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0105	0.013	CbGbCtD
Erythromycin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.013	CbGbCtD
Erythromycin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0127	CbGbCtD
Erythromycin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00996	0.0123	CbGbCtD
Erythromycin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00901	0.0111	CbGbCtD
Erythromycin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00864	0.0107	CbGbCtD
Erythromycin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00781	0.00965	CbGbCtD
Erythromycin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00778	0.00962	CbGbCtD
Erythromycin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00755	0.00933	CbGbCtD
Erythromycin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00683	0.00844	CbGbCtD
Erythromycin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00683	0.00844	CbGbCtD
Erythromycin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00655	0.00809	CbGbCtD
Erythromycin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00635	0.00785	CbGbCtD
Erythromycin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00597	0.00738	CbGbCtD
Erythromycin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00597	0.00738	CbGbCtD
Erythromycin—MLNR—digestive system—acquired immunodeficiency syndrome	0.00561	0.201	CbGeAlD
Erythromycin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0054	0.00667	CbGbCtD
Erythromycin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0054	0.00667	CbGbCtD
Erythromycin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00506	0.00626	CbGbCtD
Erythromycin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00466	0.00576	CbGbCtD
Erythromycin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00452	0.00559	CbGbCtD
Erythromycin—MLNR—nervous system—acquired immunodeficiency syndrome	0.00434	0.155	CbGeAlD
Erythromycin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00409	0.00506	CbGbCtD
Erythromycin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00409	0.00506	CbGbCtD
Erythromycin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00392	0.00485	CbGbCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00151	0.0718	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00101	0.0481	CbGpPWpGaD
Erythromycin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000951	0.0341	CbGeAlD
Erythromycin—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000924	0.0331	CbGeAlD
Erythromycin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000918	0.0329	CbGeAlD
Erythromycin—MLNR—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000917	0.0435	CbGpPWpGaD
Erythromycin—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000912	0.0327	CbGeAlD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000829	0.0393	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000773	0.0367	CbGpPWpGaD
Erythromycin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000689	0.0247	CbGeAlD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000615	0.0292	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000566	0.0269	CbGpPWpGaD
Erythromycin—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.00056	0.0201	CbGeAlD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000556	0.0264	CbGpPWpGaD
Erythromycin—SLC22A7—brain—acquired immunodeficiency syndrome	0.000546	0.0196	CbGeAlD
Erythromycin—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000514	0.0184	CbGeAlD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000512	0.0243	CbGpPWpGaD
Erythromycin—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000492	0.0233	CbGpPWpGaD
Erythromycin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000487	0.0175	CbGeAlD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000482	0.0228	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000482	0.0228	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000468	0.0222	CbGpPWpGaD
Erythromycin—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000467	0.0168	CbGeAlD
Erythromycin—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000438	0.0157	CbGeAlD
Erythromycin—ABCC1—blood—acquired immunodeficiency syndrome	0.000437	0.0157	CbGeAlD
Erythromycin—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000433	0.0155	CbGeAlD
Erythromycin—MLNR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000423	0.0201	CbGpPWpGaD
Erythromycin—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000417	0.0149	CbGeAlD
Erythromycin—ABCC1—vagina—acquired immunodeficiency syndrome	0.000405	0.0145	CbGeAlD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000401	0.019	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000397	0.0188	CbGpPWpGaD
Erythromycin—ABCC1—lung—acquired immunodeficiency syndrome	0.000383	0.0137	CbGeAlD
Erythromycin—Hallucination—Efavirenz—acquired immunodeficiency syndrome	0.000381	0.00268	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00038	0.018	CbGpPWpGaD
Erythromycin—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00038	0.00267	CcSEcCtD
Erythromycin—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.00267	CcSEcCtD
Erythromycin—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.000379	0.00267	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000377	0.0179	CbGpPWpGaD
Erythromycin—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.00262	CcSEcCtD
Erythromycin—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.000372	0.00262	CcSEcCtD
Erythromycin—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000371	0.00261	CcSEcCtD
Erythromycin—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00259	CcSEcCtD
Erythromycin—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000368	0.00259	CcSEcCtD
Erythromycin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000368	0.00259	CcSEcCtD
Erythromycin—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00259	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000366	0.0174	CbGpPWpGaD
Erythromycin—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.00258	CcSEcCtD
Erythromycin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000366	0.0131	CbGeAlD
Erythromycin—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000365	0.0173	CbGpPWpGaD
Erythromycin—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.000364	0.00256	CcSEcCtD
Erythromycin—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00255	CcSEcCtD
Erythromycin—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.000361	0.00254	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00253	CcSEcCtD
Erythromycin—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00251	CcSEcCtD
Erythromycin—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000356	0.00251	CcSEcCtD
Erythromycin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000355	0.0025	CcSEcCtD
Erythromycin—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000355	0.0127	CbGeAlD
Erythromycin—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.00249	CcSEcCtD
Erythromycin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000353	0.0126	CbGeAlD
Erythromycin—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000351	0.00247	CcSEcCtD
Erythromycin—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000351	0.0126	CbGeAlD
Erythromycin—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00247	CcSEcCtD
Erythromycin—Pain—Didanosine—acquired immunodeficiency syndrome	0.00035	0.00247	CcSEcCtD
Erythromycin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000349	0.0125	CbGeAlD
Erythromycin—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00244	CcSEcCtD
Erythromycin—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00243	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000344	0.0163	CbGpPWpGaD
Erythromycin—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.00242	CcSEcCtD
Erythromycin—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.0024	CcSEcCtD
Erythromycin—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.0024	CcSEcCtD
Erythromycin—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.0024	CcSEcCtD
Erythromycin—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00034	0.00239	CcSEcCtD
Erythromycin—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000339	0.00239	CcSEcCtD
Erythromycin—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.00238	CcSEcCtD
Erythromycin—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00237	CcSEcCtD
Erythromycin—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00237	CcSEcCtD
Erythromycin—CYP3A5—blood—acquired immunodeficiency syndrome	0.000336	0.0121	CbGeAlD
Erythromycin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000335	0.00236	CcSEcCtD
Erythromycin—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000334	0.00235	CcSEcCtD
Erythromycin—CYP2B6—blood—acquired immunodeficiency syndrome	0.000334	0.012	CbGeAlD
Erythromycin—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.00234	CcSEcCtD
Erythromycin—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000331	0.0119	CbGeAlD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00033	0.0157	CbGpPWpGaD
Erythromycin—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000328	0.00231	CcSEcCtD
Erythromycin—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00229	CcSEcCtD
Erythromycin—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00229	CcSEcCtD
Erythromycin—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.00228	CcSEcCtD
Erythromycin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000324	0.00228	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000323	0.0153	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000323	0.0153	CbGpPWpGaD
Erythromycin—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000323	0.00227	CcSEcCtD
Erythromycin—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00032	0.00225	CcSEcCtD
Erythromycin—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00225	CcSEcCtD
Erythromycin—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000319	0.00224	CcSEcCtD
Erythromycin—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000319	0.00224	CcSEcCtD
Erythromycin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000318	0.00224	CcSEcCtD
Erythromycin—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000317	0.00223	CcSEcCtD
Erythromycin—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00222	CcSEcCtD
Erythromycin—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00222	CcSEcCtD
Erythromycin—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.0022	CcSEcCtD
Erythromycin—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00219	CcSEcCtD
Erythromycin—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000312	0.0112	CbGeAlD
Erythromycin—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00219	CcSEcCtD
Erythromycin—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00219	CcSEcCtD
Erythromycin—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00031	0.00218	CcSEcCtD
Erythromycin—CYP2B6—vagina—acquired immunodeficiency syndrome	0.00031	0.0111	CbGeAlD
Erythromycin—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000309	0.00218	CcSEcCtD
Erythromycin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00218	CcSEcCtD
Erythromycin—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00217	CcSEcCtD
Erythromycin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000308	0.00216	CcSEcCtD
Erythromycin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000306	0.011	CbGeAlD
Erythromycin—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.00215	CcSEcCtD
Erythromycin—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000305	0.00214	CcSEcCtD
Erythromycin—Pain—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00214	CcSEcCtD
Erythromycin—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00214	CcSEcCtD
Erythromycin—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000304	0.00214	CcSEcCtD
Erythromycin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000302	0.00213	CcSEcCtD
Erythromycin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000301	0.00212	CcSEcCtD
Erythromycin—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.0003	0.00211	CcSEcCtD
Erythromycin—Pain—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00211	CcSEcCtD
Erythromycin—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000299	0.00211	CcSEcCtD
Erythromycin—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00209	CcSEcCtD
Erythromycin—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00207	CcSEcCtD
Erythromycin—CYP3A5—lung—acquired immunodeficiency syndrome	0.000295	0.0106	CbGeAlD
Erythromycin—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.00207	CcSEcCtD
Erythromycin—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000294	0.00207	CcSEcCtD
Erythromycin—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00207	CcSEcCtD
Erythromycin—CYP2B6—lung—acquired immunodeficiency syndrome	0.000293	0.0105	CbGeAlD
Erythromycin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000293	0.00206	CcSEcCtD
Erythromycin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000292	0.00205	CcSEcCtD
Erythromycin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000291	0.00205	CcSEcCtD
Erythromycin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000291	0.00205	CcSEcCtD
Erythromycin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00029	0.00204	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000289	0.0137	CbGpPWpGaD
Erythromycin—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000289	0.00203	CcSEcCtD
Erythromycin—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.00203	CcSEcCtD
Erythromycin—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00203	CcSEcCtD
Erythromycin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00202	CcSEcCtD
Erythromycin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000287	0.00202	CcSEcCtD
Erythromycin—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.00201	CcSEcCtD
Erythromycin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000286	0.00201	CcSEcCtD
Erythromycin—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.002	CcSEcCtD
Erythromycin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.002	CcSEcCtD
Erythromycin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.002	CcSEcCtD
Erythromycin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000283	0.002	CcSEcCtD
Erythromycin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000283	0.00199	CcSEcCtD
Erythromycin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000282	0.00199	CcSEcCtD
Erythromycin—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00198	CcSEcCtD
Erythromycin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000281	0.00198	CcSEcCtD
Erythromycin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00028	0.00197	CcSEcCtD
Erythromycin—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00197	CcSEcCtD
Erythromycin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000278	0.00196	CcSEcCtD
Erythromycin—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00195	CcSEcCtD
Erythromycin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000277	0.00195	CcSEcCtD
Erythromycin—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000274	0.00193	CcSEcCtD
Erythromycin—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00193	CcSEcCtD
Erythromycin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000272	0.00191	CcSEcCtD
Erythromycin—ABCC1—brain—acquired immunodeficiency syndrome	0.000271	0.00973	CbGeAlD
Erythromycin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00191	CcSEcCtD
Erythromycin—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000271	0.00972	CbGeAlD
Erythromycin—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.0019	CcSEcCtD
Erythromycin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.00189	CcSEcCtD
Erythromycin—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00189	CcSEcCtD
Erythromycin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000267	0.00188	CcSEcCtD
Erythromycin—ABCB1—retina—acquired immunodeficiency syndrome	0.000267	0.00957	CbGeAlD
Erythromycin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00186	CcSEcCtD
Erythromycin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000265	0.00949	CbGeAlD
Erythromycin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00186	CcSEcCtD
Erythromycin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00186	CcSEcCtD
Erythromycin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.00185	CcSEcCtD
Erythromycin—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000262	0.0094	CbGeAlD
Erythromycin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00185	CcSEcCtD
Erythromycin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000262	0.00185	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000262	0.0124	CbGpPWpGaD
Erythromycin—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000261	0.00936	CbGeAlD
Erythromycin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000261	0.00184	CcSEcCtD
Erythromycin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000261	0.00183	CcSEcCtD
Erythromycin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00183	CcSEcCtD
Erythromycin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00182	CcSEcCtD
Erythromycin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000258	0.00182	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000258	0.0123	CbGpPWpGaD
Erythromycin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000258	0.00182	CcSEcCtD
Erythromycin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.0018	CcSEcCtD
Erythromycin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000255	0.00179	CcSEcCtD
Erythromycin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00179	CcSEcCtD
Erythromycin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000253	0.00178	CcSEcCtD
Erythromycin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000253	0.00178	CcSEcCtD
Erythromycin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000252	0.00904	CbGeAlD
Erythromycin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000252	0.00177	CcSEcCtD
Erythromycin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000252	0.00177	CcSEcCtD
Erythromycin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.00177	CcSEcCtD
Erythromycin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00176	CcSEcCtD
Erythromycin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000248	0.00175	CcSEcCtD
Erythromycin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00174	CcSEcCtD
Erythromycin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00174	CcSEcCtD
Erythromycin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00173	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000246	0.0117	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000246	0.0117	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000246	0.0117	CbGpPWpGaD
Erythromycin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.00173	CcSEcCtD
Erythromycin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00173	CcSEcCtD
Erythromycin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00172	CcSEcCtD
Erythromycin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000244	0.00172	CcSEcCtD
Erythromycin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000243	0.00171	CcSEcCtD
Erythromycin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000243	0.00171	CcSEcCtD
Erythromycin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00171	CcSEcCtD
Erythromycin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00171	CcSEcCtD
Erythromycin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.0017	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00024	0.0114	CbGpPWpGaD
Erythromycin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00024	0.00169	CcSEcCtD
Erythromycin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00168	CcSEcCtD
Erythromycin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000237	0.00167	CcSEcCtD
Erythromycin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00166	CcSEcCtD
Erythromycin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00166	CcSEcCtD
Erythromycin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00166	CcSEcCtD
Erythromycin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00166	CcSEcCtD
Erythromycin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00165	CcSEcCtD
Erythromycin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.00165	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000234	0.0111	CbGpPWpGaD
Erythromycin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00164	CcSEcCtD
Erythromycin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00164	CcSEcCtD
Erythromycin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000232	0.00164	CcSEcCtD
Erythromycin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000232	0.00163	CcSEcCtD
Erythromycin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00162	CcSEcCtD
Erythromycin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00161	CcSEcCtD
Erythromycin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000228	0.00161	CcSEcCtD
Erythromycin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.0016	CcSEcCtD
Erythromycin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000227	0.0016	CcSEcCtD
Erythromycin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000227	0.0016	CcSEcCtD
Erythromycin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000226	0.00159	CcSEcCtD
Erythromycin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.00159	CcSEcCtD
Erythromycin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000225	0.00158	CcSEcCtD
Erythromycin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000224	0.00158	CcSEcCtD
Erythromycin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00158	CcSEcCtD
Erythromycin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000223	0.00157	CcSEcCtD
Erythromycin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00157	CcSEcCtD
Erythromycin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00156	CcSEcCtD
Erythromycin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00156	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000221	0.0105	CbGpPWpGaD
Erythromycin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000221	0.00156	CcSEcCtD
Erythromycin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00155	CcSEcCtD
Erythromycin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00155	CcSEcCtD
Erythromycin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000219	0.00154	CcSEcCtD
Erythromycin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00154	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000217	0.0103	CbGpPWpGaD
Erythromycin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00152	CcSEcCtD
Erythromycin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.00151	CcSEcCtD
Erythromycin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00151	CcSEcCtD
Erythromycin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.0015	CcSEcCtD
Erythromycin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.00149	CcSEcCtD
Erythromycin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00149	CcSEcCtD
Erythromycin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.00149	CcSEcCtD
Erythromycin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000211	0.00149	CcSEcCtD
Erythromycin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00148	CcSEcCtD
Erythromycin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00147	CcSEcCtD
Erythromycin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000208	0.00147	CcSEcCtD
Erythromycin—CYP2B6—brain—acquired immunodeficiency syndrome	0.000207	0.00743	CbGeAlD
Erythromycin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00145	CcSEcCtD
Erythromycin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00145	CcSEcCtD
Erythromycin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00145	CcSEcCtD
Erythromycin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000205	0.00734	CbGeAlD
Erythromycin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00144	CcSEcCtD
Erythromycin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000203	0.00143	CcSEcCtD
Erythromycin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00142	CcSEcCtD
Erythromycin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.00141	CcSEcCtD
Erythromycin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00139	CcSEcCtD
Erythromycin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00139	CcSEcCtD
Erythromycin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000197	0.00707	CbGeAlD
Erythromycin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000197	0.00139	CcSEcCtD
Erythromycin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000197	0.00138	CcSEcCtD
Erythromycin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00138	CcSEcCtD
Erythromycin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.00137	CcSEcCtD
Erythromycin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.00135	CcSEcCtD
Erythromycin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00135	CcSEcCtD
Erythromycin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00135	CcSEcCtD
Erythromycin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00134	CcSEcCtD
Erythromycin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00134	CcSEcCtD
Erythromycin—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000191	0.00904	CbGpPWpGaD
Erythromycin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00134	CcSEcCtD
Erythromycin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00134	CcSEcCtD
Erythromycin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.00019	0.0068	CbGeAlD
Erythromycin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00133	CcSEcCtD
Erythromycin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00133	CcSEcCtD
Erythromycin—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000187	0.00672	CbGeAlD
Erythromycin—MLNR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000187	0.00887	CbGpPWpGaD
Erythromycin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.00131	CcSEcCtD
Erythromycin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.00129	CcSEcCtD
Erythromycin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00129	CcSEcCtD
Erythromycin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00129	CcSEcCtD
Erythromycin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.00129	CcSEcCtD
Erythromycin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000183	0.00129	CcSEcCtD
Erythromycin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000183	0.00866	CbGpPWpGaD
Erythromycin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00128	CcSEcCtD
Erythromycin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000181	0.00128	CcSEcCtD
Erythromycin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00127	CcSEcCtD
Erythromycin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00126	CcSEcCtD
Erythromycin—ABCB1—blood—acquired immunodeficiency syndrome	0.000179	0.0064	CbGeAlD
Erythromycin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.00125	CcSEcCtD
Erythromycin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.00125	CcSEcCtD
Erythromycin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00123	CcSEcCtD
Erythromycin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00123	CcSEcCtD
Erythromycin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.00122	CcSEcCtD
Erythromycin—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000173	0.00619	CbGeAlD
Erythromycin—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000172	0.00617	CbGeAlD
Erythromycin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00121	CcSEcCtD
Erythromycin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Erythromycin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000171	0.0012	CcSEcCtD
Erythromycin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.0012	CcSEcCtD
Erythromycin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.0012	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000169	0.008	CbGpPWpGaD
Erythromycin—ABCB1—vagina—acquired immunodeficiency syndrome	0.000166	0.00593	CbGeAlD
Erythromycin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00116	CcSEcCtD
Erythromycin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.00116	CcSEcCtD
Erythromycin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.00115	CcSEcCtD
Erythromycin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00115	CcSEcCtD
Erythromycin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.00114	CcSEcCtD
Erythromycin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00114	CcSEcCtD
Erythromycin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00112	CcSEcCtD
Erythromycin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.00111	CcSEcCtD
Erythromycin—ABCB1—lung—acquired immunodeficiency syndrome	0.000157	0.00561	CbGeAlD
Erythromycin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.0011	CcSEcCtD
Erythromycin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00109	CcSEcCtD
Erythromycin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Erythromycin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.00108	CcSEcCtD
Erythromycin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00107	CcSEcCtD
Erythromycin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.00106	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000148	0.00704	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000148	0.00701	CbGpPWpGaD
Erythromycin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Erythromycin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00103	CcSEcCtD
Erythromycin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00103	CcSEcCtD
Erythromycin—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000145	0.0052	CbGeAlD
Erythromycin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00101	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000142	0.00673	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000142	0.00673	CbGpPWpGaD
Erythromycin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000988	CcSEcCtD
Erythromycin—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.00014	0.005	CbGeAlD
Erythromycin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.00098	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000139	0.00659	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000139	0.00659	CbGpPWpGaD
Erythromycin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000967	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000134	0.00637	CbGpPWpGaD
Erythromycin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000923	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000128	0.00609	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000126	0.00599	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000126	0.00599	CbGpPWpGaD
Erythromycin—ABCB1—brain—acquired immunodeficiency syndrome	0.000111	0.00397	CbGeAlD
Erythromycin—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000107	0.00384	CbGeAlD
Erythromycin—MLNR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000106	0.00502	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000104	0.00494	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000103	0.00488	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000103	0.00488	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000102	0.00484	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000102	0.00482	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.6e-05	0.00455	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.53e-05	0.00452	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.46e-05	0.00449	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.19e-05	0.00436	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	8.91e-05	0.00423	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.77e-05	0.00416	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.65e-05	0.0041	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.93e-05	0.00376	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.46e-05	0.00354	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.46e-05	0.00354	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	6.75e-05	0.0032	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	6.75e-05	0.0032	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	6.57e-05	0.00312	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	6.42e-05	0.00305	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.67e-05	0.00269	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.59e-05	0.00265	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.5e-05	0.00261	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	5.35e-05	0.00254	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.25e-05	0.00249	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.11e-05	0.00242	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5e-05	0.00237	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	4.88e-05	0.00232	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	4.81e-05	0.00228	CbGpPWpGaD
Erythromycin—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.59e-05	0.00218	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	4.55e-05	0.00216	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	4.34e-05	0.00206	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	4.2e-05	0.00199	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.09e-05	0.00194	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.97e-05	0.00188	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.92e-05	0.00186	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	3.91e-05	0.00185	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.57e-05	0.00169	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.53e-05	0.00167	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.49e-05	0.00166	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.16e-05	0.0015	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.16e-05	0.0015	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	3.1e-05	0.00147	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	3.03e-05	0.00144	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.95e-05	0.0014	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.94e-05	0.00139	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.67e-05	0.00127	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.64e-05	0.00125	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.58e-05	0.00122	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.57e-05	0.00122	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.29e-05	0.00109	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.09e-05	0.000993	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	2.05e-05	0.000973	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.99e-05	0.000944	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.95e-05	0.000923	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.88e-05	0.000894	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.83e-05	0.000867	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.79e-05	0.00085	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.74e-05	0.000823	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.55e-05	0.000737	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.41e-05	0.000669	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000667	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.27e-05	0.000601	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.2e-05	0.000569	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	9.33e-06	0.000442	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	8.83e-06	0.000419	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.52e-06	0.000404	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	8.39e-06	0.000398	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	7.32e-06	0.000347	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.16e-06	0.000339	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	5.41e-06	0.000257	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	5.29e-06	0.000251	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	4.78e-06	0.000227	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.99e-06	0.000189	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.19e-06	0.000151	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.46e-06	0.000117	CbGpPWpGaD
